Kin-Hung P. Yu
0000-0002-9246-4368
Publication & Citation Trends
Publications
0 total
Roxadustat for the treatment of anemia in patients with lower‐risk myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study OA
Cited by 54
Semantic Scholar
Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.
Cited by 117
Semantic Scholar
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study OA
Cited by 87
Semantic Scholar
POS-282 ROXADUSTAT TREATMENT RESULTS IN CONSISTENT IMPROVEMENTS IN HEMOGLOBIN (HB) VERSUS PLACEBO: AN ANALYSIS OF THREE MULTINATIONAL RCTS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) OA
Cited by 1
Semantic Scholar
Roxadustat for CKD-related Anemia in Non-dialysis Patients OA
Cited by 102
Semantic Scholar
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis. OA
Cited by 481
Semantic Scholar
Roxadustat (FG4592; ASP1517; AZD9941) in the Treatment of Anemia in Patients with Lower Risk Myelodysplastic Syndrome (LR-MDS) and Low Red Blood Cell (RBC) Transfusion Burden (LTB) OA
Cited by 18
Semantic Scholar
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis. OA
Cited by 464
Semantic Scholar
Research Topics
Erythropoietin and Anemia Treatment
(36)
Hemoglobinopathies and Related Disorders
(15)
Dialysis and Renal Disease Management
(13)
Lung Cancer Treatments and Mutations
(7)
Iron Metabolism and Disorders
(7)
Affiliations
Apollomics (United States)
FibroGen (United States)
University of California, Davis